106 related articles for article (PubMed ID: 1943081)
1. Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Yousuf N; Khan S; Sheikh Y; Hyams D; Bokhari J; Raza A
J Surg Res; 1991 Dec; 51(6):457-62. PubMed ID: 1943081
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
Miller MA; Mazewski CM; Yousuf N; Sheikh Y; White LM; Yanik GA; Hyams DM; Lampkin BC; Raza A
J Histochem Cytochem; 1991 Apr; 39(4):407-12. PubMed ID: 2005370
[TBL] [Abstract][Full Text] [Related]
3. Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Acta Pathol Jpn; 1993 Oct; 43(10):590-6. PubMed ID: 8291447
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
Hoshino T; Ito S; Asai A; Shibuya M; Prados MD; Dodson BA; Davis RL; Wilson CB
Int J Cancer; 1992 Jan; 50(1):1-5. PubMed ID: 1728598
[TBL] [Abstract][Full Text] [Related]
5. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
6. Cell kinetics of head and neck cancers.
Kotelnikov VM; Coon JS IV; Haleem A; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Griem K; Preisler HD
Clin Cancer Res; 1995 May; 1(5):527-37. PubMed ID: 9816012
[TBL] [Abstract][Full Text] [Related]
7. In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
Raza A; Yousuf N; Bohkari SA; Sheikh Y; Akhtar S; Chughtai S; Umerani A; Mehdi SA; Miller MA; Masterson M
Leuk Res; 1992; 16(3):299-306. PubMed ID: 1560677
[TBL] [Abstract][Full Text] [Related]
8. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
[TBL] [Abstract][Full Text] [Related]
9. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
[TBL] [Abstract][Full Text] [Related]
10. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
Macapinlac HA; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
[TBL] [Abstract][Full Text] [Related]
12. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
14. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Nishijima Y; Koiso K; Harada M
Cancer; 1990 Aug; 66(3):509-14. PubMed ID: 2194646
[TBL] [Abstract][Full Text] [Related]
15. A novel triple label method validates the double label technique of defining cell cycle kinetics in HL-60 cells.
Mehdi A; Bokhari SA; Yousuf N; Umerani A; Chughtai S; Hussain F; Raza A
Anticancer Res; 1992; 12(5):1443-6. PubMed ID: 1444205
[TBL] [Abstract][Full Text] [Related]
16. The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain.
Mourad WA; Connelly JH; Sembera DL; Atkinson EN; Bruner JM
Hum Pathol; 1993 Feb; 24(2):206-10. PubMed ID: 8432516
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of DNA index and BrdU labeling index with clinicopathological factors in colorectal carcinoma].
Takegawa S
Nihon Geka Gakkai Zasshi; 1992 Jun; 93(6):607-15. PubMed ID: 1630437
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two double labeling techniques to measure cell cycle kinetics in myeloid leukemias.
Yousuf N; Yanik GA; George BA; Masterson M; Mazewski CM; White LM; Miller MA; Lampkin BC; Raza A
Anticancer Res; 1991; 11(3):1195-9. PubMed ID: 1888149
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical double staining with immunogold-silver and alkaline phosphatase to identify nuclear markers of cellular proliferation.
Shibuya M; Ito S; Davis RL; Hoshino T
Biotech Histochem; 1993 Jan; 68(1):17-9. PubMed ID: 8383543
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of human lung cancer. Correlation with histologic type and stage.
Moran RE; Melamed MR
Anal Quant Cytol; 1984 Jun; 6(2):99-104. PubMed ID: 6205621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
